Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | JBIO | AZN | AMGN | GILD | BMY |
| Company | Jade Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 16.01 | 198.71 | 340.98 | 139.00 | 59.12 |
| High | 16.37 | 202.00 | 341.87 | 139.39 | 59.23 |
| Low | 15.45 | 196.95 | 335.06 | 137.15 | 57.65 |
| Latest | 16.36 | 200.81 | 340.00 | 138.80 | 57.67 |
| Change | +0.19 | -2.02 | -2.57 | -1.33 | -1.66 |
| % Change | +1.18% | -1.00% | -0.75% | -0.95% | -2.80% |
| Volume | 602,200 | 2,450,800 | 3,159,400 | 5,434,500 | 8,983,900 |
| 20-Day Average Volume | 621,405 | 1,872,250 | 2,678,550 | 6,110,090 | 13,496,936 |
| Previous Close | 16.17 | 202.83 | 342.57 | 140.13 | 59.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.31 | 192.14 | 355.12 | 140.67 | 59.13 |
| 20-Day Raw Stochastic | 97.73% | 82.38% | 10.96% | 31.70% | 21.13% |
| 20-Day Relative Strength | 61.06 | 56.94 | 38.99 | 46.55 | 45.70 |
| Weighted Alpha | +28.63 | +49.74 | +18.09 | +32.92 | +18.93 |
| Today's Opinion | 88% Buy | 88% Buy | 24% Buy | 40% Buy | 48% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 48% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +23.38% since 03/30/26 | +3.57% since 03/30/26 | -2.58% since 03/30/26 | +1.80% since 03/30/26 | -3.45% since 03/30/26 |
| Low | 13.51 on 03/31/26 | 193.55 on 03/31/26 | 335.06 on 04/07/26 | 137.15 on 04/07/26 | 57.65 on 04/07/26 |
| High | 16.44 on 04/01/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +16.44% since 03/06/26 | +3.39% since 03/06/26 | -7.99% since 03/06/26 | -3.56% since 03/06/26 | -4.35% since 03/06/26 |
| Low | 12.91 on 03/24/26 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 16.44 on 04/01/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +24.08% since 01/07/26 | +5.51% since 01/07/26 | -0.48% since 01/07/26 | +11.62% since 01/07/26 | +1.67% since 01/07/26 |
| Low | 12.45 on 01/12/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 17.50 on 02/04/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +80.97% since 10/07/25 | +16.93% since 10/07/25 | +15.04% since 10/07/25 | +18.86% since 10/07/25 | +29.13% since 10/07/25 |
| Low | 8.36 on 11/07/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 17.71 on 12/19/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 797,440 | 314,570,656 | 184,668,512 | 173,932,464 | 121,136,144 |
| Shares Outstanding, K | 49,316 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -127,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -67,580,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.03 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 03/06/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 04/24/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.22 | 15.92 | 17.14 | 9.69 |